Frequency of antithyroid antibodies in patients with primary biliary cholangitis.

anti-thyroglobulin antibodies antithyroid antibodies antithyroperoxidase antibodies anti–thyroid-stimulating hormone receptor antibodies autoimmunity primary biliary cholangitis

Journal

Laboratory medicine
ISSN: 1943-7730
Titre abrégé: Lab Med
Pays: England
ID NLM: 0250641

Informations de publication

Date de publication:
28 Aug 2023
Historique:
medline: 28 8 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: aheadofprint

Résumé

Primary biliary cholangitis (PBC) is an autoimmune disease of liver that may be associated with other conditions, including autoimmune thyroid diseases. We aimed to investigate the frequency of anti-thyroperoxidase antibodies (TPO-Ab), antithyroglobulin antibodies (TG-Ab), and anti-thyrotropin receptor antibodies (TSHR-Ab) in Tunisian patients with PBC. Sera of 80 patients with PBC were collected over a 9-year period. A total of 189 healthy blood donors (HBD) were included in the control group. Measurements of TPO-Ab and TG-Ab were performed using indirect enzyme-linked immunosorbent assay (ELISA). Competitive ELISA was used to assess TSHR-Ab. Antithyroid antibodies (ATA) were significantly more frequent in PBC patients than in the control group (13.7% vs 1.6%; P < 10-3). Out of 11 patients with ATA, 10 (90.9%) were female. Nine patients and 2 HBD had TPO-Ab (11.2% vs 1%; P < 10-3). TG-Ab were more frequent in patients than in healthy subjects but the difference was not statistically significant (6.2% vs 1.6%; P = .1). TPO-Ab and TG-Ab were present together in 3 patients (3.7%). TSHR-Ab were absent in patients and controls. This study shows that PBC is associated with a high frequency of ATA but not TG-Ab or TSHR-Ab.

Identifiants

pubmed: 37638796
pii: 7252708
doi: 10.1093/labmed/lmad080
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Mariam Ghozzi (M)

Laboratory of Immunology, Farhat Hached University Hospital, Sousse, Tunisia.
Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia.
Research Laboratory for "Epidemiology and Immunogenetics of Viral Infections" (LR14SP02), Sahloul University Hospital, University of Sousse, Sousse, Tunisia.

Amani Mankai (A)

High School of Sciences and Techniques of Health, Tunis El Manar University, Tunis, Tunisia.
Research Unit "Obesity: Etiopathology and Treatment, UR18ES01," National Institute of Nutrition and Food Technology, Tunis, Tunisia.

Zeineb Chedly (Z)

Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia.

Ikram Mlika (I)

Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia.

Wiem Manoubi (W)

Erasmus University Medical Centre, Department of Neuroscience, Rotterdam, Netherlands.

Sarra Melayah (S)

Laboratory of Immunology, Farhat Hached University Hospital, Sousse, Tunisia.
Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia.
LR12SP11, Biochemistry Department, Sahloul University Hospital, Sousse, Tunisia.

Ibtissem Ghedira (I)

Laboratory of Immunology, Farhat Hached University Hospital, Sousse, Tunisia.
Faculty of Pharmacy, Department of Immunology, University of Monastir, Monastir, Tunisia.

Classifications MeSH